跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65,236 条关于
“CARTITUDE-2”
全部
65,236
临床试验
42,644
药物
7,309
机构
1,387
资讯
13,896
去年
Sequencing Bispecific Antibodies and CAR T-Cell Therapy in Multiple Myeloma Treatment
3年前
Cilta-cel Demonstrates Promising Results in Early and Late Relapsed Multiple Myeloma
2年前
Novel Targets and Strategic Sequencing: The Evolving Landscape of T-Cell Redirection Therapies in Multiple Myeloma
3年前
Cilta-cel Shows Significant Reduction in Disease Progression in Relapsed/Refractory Multiple Myeloma
去年
Cilta-Cel Shows Promise in Earlier Multiple Myeloma Treatment Lines
10个月前
Legend Biotech to Present Comprehensive CARVYKTI Data and First-in-Human Allogeneic CAR-T Results at ASH 2025
9个月前
CARVYKTI Shows Durable Treatment-Free Remissions at 2.5 Years in Earlier-Line Multiple Myeloma
去年
Real-World Data Reinforces Cilta-Cel Efficacy in Relapsed Multiple Myeloma, While Ide-Cel Shows Promise in CNS Involvement
去年
Cilta-Cel Demonstrates Superiority Over Standard-of-Care Regimens in Lenalidomide-Refractory Multiple Myeloma
去年
J&J's Carvykti Shows Promise in Earlier Myeloma Treatment
第 1 页,共 1390 页
上一页
下一页